Prognostic factors for the clinical severity of keratoconjunctivitis sicca in patients with Sjögren's syndrome

British Journal of Ophthalmology

Volumn 96, Issue 2, 2012, Pages 240-245

  Chung, Jin Kwon ^a,b   Kim, Mee Kum ^a,b   Wee, Won Ryang ^a,b  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; INTERLEUKIN 17; LA ANTIBODY; RHEUMATOID FACTOR; RO ANTIBODY;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; KERATOCONJUNCTIVITIS SICCA; LACRIMAL FLUID LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; SCHIRMER TEST; SJOEGREN SYNDROME;

ANTIBODIES, ANTINUCLEAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-17; KERATOCONJUNCTIVITIS; MALE; MIDDLE AGED; NEPHELOMETRY AND TURBIDIMETRY; PROGNOSIS; RHEUMATOID FACTOR; SJOGREN'S SYNDROME; TEARS;

EID: 84856060436     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2011.202812     Document Type: Article

References (23)

1. Meijer JM, Meiners' PM, Slater JJH, et al. Health-related quality of life, employment and disability in patients with Sjogren's syndrome. Rheumatology (Oxford) 2009;48:1077-82.
2. Tsubota K, Toda I, Yagi Y, et al. Three different types of dry eye syndrome. Cornea 1994;13:202-9. (Pubitemid 24129152)
3. Toker E, Yavuz S, Direskeneli H. Anti-Ro/SSA and anti-La/SSB autoantibodies in the tear fluid of patients with Sjogren's syndrome. Br J Ophthalmol 2004;88:384-7. (Pubitemid 38333719)
4. Katsifis GE, Moutsopoulos NM, Wahl SM. T lymphocytes in Sjogren's syndrome: contributors to and regulators of pathophysiology. Clin Rev Allergy Immunol 2007;32:252-64. (Pubitemid 350242571)
5. O'Brien CA, Wolin SL. A possible role for the 60-kD Ro autoantigen in a discard pathway for defective 5S rRNA precursors. Genes Dev 1994;8:2891-903. (Pubitemid 24374673)
6. Gottlieb E, Steitz JA. Function of the mammalian La protein: evidence for its action in transcription termination by RNA polymerase III. EMBO J 1989;8:851-61. (Pubitemid 19273257)
7. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8. (Pubitemid 34539104)
8. Tan EM. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 1989;44:93-151. (Pubitemid 19090837)
9. Dorner T, Egerer K, Feist E, et al. Rheumatoid factor revisited. Curr Opin Rheumatol 2004;16:246-53. (Pubitemid 38530493)
10. Boniface K, Blom B, Liu YJ, et al. From interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisited. Immunol Rev 2008;226:132-46.
11. Katsifis GE, Rekka S, Moutsopoulos NM, et al. Systemic and local interleukin-17 and linked cytokines associated with Sjogren's syndrome immunopathogenesis. Am J Pathol 2009;175:1167-77.
12. Chauhan SK, El Annan J, Ecoiffier T, et al. Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression. J Immunol 2009;182:1247-52.
13. Candon S, Gottenberg JE, Bengoufa D, et al. Quantitative assessment of antibodies to ribonucleoproteins in primary Sjogren syndrome: correlation with B-cell biomarkers and disease activity. Ann Rheum Dis 2009;68:1208-12.
14. Bron AJ, Evans VE, Smith JA. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea 2003;22:640-50. (Pubitemid 37175145)
15. Shoji J, Kitazawa M, Inada N, et al. Efficacy of tear eosinophil cationic protein level measurement using filter paper for diagnosing allergic conjunctival disorders. Jpn J Ophthalmol 2003;47:64-8.
16. Begley CG, Chalmers RL, Abetz L, et al. The relationship between habitual patient-reported symptoms and clinical signs among patients with dry eye of varying severity. Invest Ophthalmol Vis Sci 2003;44:4753-61.
17. Vissink A, Kalk WW, Mansour K, et al. Comparison of lacrimal and salivary gland involvement in Sjogren's syndrome. Arch Otolaryngol Head Neck Surg 2003;129:966-71. (Pubitemid 37087657)
18. Boire G, Craft J. Human Ro ribonucleoprotein particles: characterization of native structure and stable association with the La polypeptide. J Clin Invest 1990;85:1182-90. (Pubitemid 20123761)
19. Kolls JK, Linden A. Interleukin-17 family members and inflammation. Immunity 2004;21:467-76. (Pubitemid 39370503)
20. Zheng Y, Danilenko DM, Valdez P, et al. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 2007;445:648-51. (Pubitemid 46232884)
21. Miossec P. IL-17 and Th17 cells in human inflammatory diseases. Microbes Infect 2009;11:625-30.
22. Hashimoto T, Akiyama K, Kobayashi N, et al. Comparison of IL-17 production by helper T cells among atopic and nonatopic asthmatics and control subjects. Int Arch Allergy Immunol 2005;137(Suppl 1):51-4. (Pubitemid 40868774)
23. Nguyen CQ, Hu MH, Li Y, et al. Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjogren's syndrome: findings in humans and mice. Arthritis Rheum 2008;58:734-43. (Pubitemid 351364871)